SECURITIES AND EXCHANGE COMMISSION
                              WASHINGTON, DC 20549

                                   FORM 12b-25

                           NOTIFICATION OF LATE FILING

                                                  Commission File Number 0-28498

(Check one)

|_| Form 10-K and Form 10-KSB   |_| Form 11-K

|_| Form 20-F  |X| Form 10-Q and Form 10-QSB  |_| Form N-SAR

For period ended: March 31, 2004

|_| Transition Report on Form 10-K and Form 10-KSB

|_| Transition Report on Form 20-F

|_| Transition Report on Form 11-K

|_| Transition Report on Form 10-Q and Form 10-QSB

|_| Transition Report on Form N-SAR

For the transition period ended _____________________________________________

Read Attached Instruction Sheet Before Preparing Form.  Please Print or Type.

   Nothing in this form shall be construed to imply that the Commission has
verified any information contained herein.

   If the notification relates to a portion of the filing checked above,
identify the item(s) to which the notification relates__________________________


--------------------------------------------------------------------------------

--------------------------------------------------------------------------------


                                     PART I
                             REGISTRANT INFORMATION

Full name of registrant: Paradigm Medical Industries, Inc.

Former name if applicable: _____________________________________________________

Address of principal executive office (Street and number):

                           2355 South 1070 West
                           Salt Lake City, Utah 84119

                                     PART II
                             RULE 12b-25(b) AND (c)


         If the subject report could not be filed without unreasonable effort or
expense and the  registrant  seeks  relief  pursuant to Rule  132b-25(b),  theZT
following should be completed. (Check box if appropriate).

         (a)      The reasons described in reasonable detail in Part III of this
                  form could  not be  eliminated  without unreasonable effort or
                  expense.





  |X|            (b) The subject  annual report,  semi-annual report, transition
                  report on Form 10-K, Form 20-F, 11-K or Form N-SAR, or portion
                  thereof, will be filed on or before the fifteenth calendar day
                  following  the  prescribed due  date; or the subject quarterly
                  report  of  transition report on Form 10-Q, or portion thereof
                  will be  filed on  or before  the fifth calendar day following
                  the prescribed due date; and

         (c)      The accountant's  statement or  other exhibit required by Rule
                  12(b)-25(c) has been attached if applicable.

                                    PART III
                                    NARRATIVE

         State below in  reasonable  detail the  reasons  why Forms 10-K,  11-K,
10-Q,  N-SAR or the  transition  report or portion  thereof,  could not be filed
within the prescribed time period. (Attach extra sheets if needed.)

         The Form 10-QSB cannot be completed  within the  requested  time period
due  to the  additional  time  required  to  complete  the  unaudited  financial
statements  of  Registrant,  primarily  as a  result  of the  recent  change  in
Registrant's management resulting from the appointment by the Board of Directors
on March  18,  2004 of John Y.  Yoon as  Registrant's  new  President  and Chief
Executive  Officer,  replacing  Jeffrey Poore who had served in those  positions
from March 19, 2003 to March 18, 2004.


                                     PART IV
                                OTHER INFORMATION


(1)  Name  and  telephone  number  of  person  to  contact  in  regard  to  this
notification

       Randall A. Mackey                (801)               575-5000
       -----(name)-------------------(area code)-----(telephone number)--------

(2) Have all other  periodic  reports  required under Section 13 or 15(d) of the
Securities  Exchange Act of 1934 or Section 30 of the Investment  Company Act of
1940  during the  preceding  12 months  (or for such  shorter)  period  that the
registrant  was  required to file such  report(s)  been filed?  If answer is no,
identify report(s).

         |X|Yes    |_| No

(3) Is it anticipated that any significant  change in results of operations from
the  corresponding  period for the last  fiscal  year will be  reflected  by the
earnings statements to be included in the subject report or portion thereof?

If so, attach an explanation of the  anticipated  change,  both  narratively and
quantitatively, and, if appropriate, state the reasons why a reasonable estimate
of the results cannot be made.

         |_|Yes    |X| No

                        Paradigm Medical Industries, Inc.
                        ---------------------------------
                  (Name of Registrant as Specified in Charter)


Has  caused  this  notification  to be signed on its  behalf by the  undersigned
hereunto duly authorized.



Date:   May 17, 2004                      By: /s/ John Y. Yoon
                                          --------------------------------------
                                           John Y. Yoon
                                           President and Chief Executive Officer